Market Business Insights ×
📩 [email protected] | 📞 +1 (212) 951-1369

Request Sample/Pricing Details:

💬

Anesthesia and Respiratory Devices Market Size Worth USD 72.6 Bn by 2035

Published: Aug 17, 2026 By Mrudula Shah Analysis: MBI

According to analysts at Market Business Insights, the Global Anesthesia and Respiratory Devices Market size is worth USD 39.8 Billion in 2025 and is projected to reach USD 72.6 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 6.2% from 2026 to 2035. Key trends include increasing surgical procedures, rising prevalence of chronic respiratory diseases, expansion of critical care infrastructure, growing adoption of portable respiratory systems, digital monitoring integration, connected healthcare platforms, AI-enabled clinical technologies, home healthcare expansion, and increasing demand for interoperable medical devices.

Anesthesia and Respiratory Devices Market Overview

The global Anesthesia and Respiratory Devices Market is witnessing steady growth as healthcare systems expand surgical capacity, intensive care infrastructure, emergency treatment capabilities, and long-term respiratory disease management services. Anesthesia and respiratory devices play a critical role across operating rooms, intensive care units, emergency departments, ambulatory surgical centers, specialty clinics, and home healthcare environments.

Increasing surgical volumes, aging populations, and the growing burden of chronic diseases are strengthening demand for anesthesia workstations, respiratory support equipment, ventilators, airway management systems, oxygen therapy devices, monitoring platforms, and related technologies. Healthcare providers are increasingly prioritizing reliable equipment capable of supporting patient safety, procedural efficiency, and continuous respiratory management.

Healthcare digitization is further transforming procurement priorities. Hospitals and healthcare networks are increasingly seeking connected devices capable of integrating with electronic medical records, centralized monitoring platforms, and hospital information systems. Advanced digital systems incorporating automated controls, remote monitoring, predictive maintenance, and data analytics are gaining traction as healthcare providers seek to improve workflow efficiency and clinical decision-making.

North America currently dominates the market, accounting for approximately 38% of global revenue in 2025, supported by advanced healthcare infrastructure, strong purchasing power, and widespread adoption of Digital Clinical technologies. Europe continues to benefit from hospital modernization and respiratory disease management initiatives, while Asia Pacific is expected to witness significant expansion due to healthcare infrastructure development, rising healthcare expenditure, and growing patient populations. Latin America and the Middle East & Africa are also creating opportunities through critical care investments and healthcare system modernization.

Overall, the Anesthesia and Respiratory Devices Market is expected to maintain robust long-term growth as healthcare organizations increasingly invest in advanced, connected, portable, and patient-centered technologies across institutional and home-based care settings.

GE HealthCare Expanded Integrated Anesthesia Workstation Capabilities

  • March 2026 — GE HealthCare expanded integrated anesthesia workstation capabilities, strengthening perioperative workflow efficiency and supporting healthcare providers’ growing demand for advanced anesthesia technologies.

Key Takeaways from the Report

  • Increasing surgical volumes, aging populations, and expanding healthcare access are accelerating demand for anesthesia and respiratory equipment worldwide.
  • Respiratory Devices represented nearly 62% of overall market demand in 2025, maintaining their position as the leading product category.
  • Chronic respiratory diseases, including chronic obstructive pulmonary disease, asthma, sleep-disordered breathing, and respiratory infections, are creating sustained demand for respiratory support technologies.
  • Portable Systems are projected to record a CAGR exceeding 7% during the forecast period as healthcare delivery increasingly shifts toward decentralized and home-based treatment models.
  • Hospitals remain the leading end-use segment due to extensive surgical activity, intensive care requirements, and broad patient coverage.
  • Home healthcare is emerging as one of the fastest-growing application environments as healthcare systems seek to reduce inpatient burdens and support long-term respiratory care outside hospitals.
  • Advanced digital systems are gaining momentum as healthcare providers prioritize interoperability, remote monitoring, automated alerts, predictive maintenance, and data integration.
  • Rising critical care infrastructure investments are supporting procurement of comprehensive anesthesia and respiratory equipment portfolios across developed and emerging healthcare markets.
  • E-procurement platforms are gaining importance as healthcare organizations increasingly adopt digital purchasing processes to improve vendor comparison, transparency, and supply chain efficiency.
  • Artificial intelligence, connected monitoring, cloud-enabled services, and enterprise orchestration are creating new opportunities for medical device manufacturers and healthcare technology providers.
  • North America remains the dominant regional market, while Asia Pacific represents a highly dynamic growth environment supported by healthcare infrastructure expansion and increasing healthcare expenditure.

Top Players

  • Medtronic
  • GE HealthCare
  • Philips
  • Drägerwerk AG
  • Fisher & Paykel Healthcare
  • ResMed
  • Mindray
  • Hamilton Medical
  • Getinge
  • Masimo

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events such as the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest Announcement

  • October 2025 — ResMed launched advanced remote monitoring enhancements for home respiratory care, supporting the continued shift toward connected and decentralized respiratory treatment models.
Share Insights: